賽隆藥業(002898.SZ):3.29億元成功競得珠海香洲區商業性辦公用地
格隆匯 6 月 30日丨賽隆藥業(002898.SZ)公佈,之前公告披露,子公司珠海賽隆國際投資有限公司擬參與競拍位於珠海市香洲區珠海大道南側、南灣大道西側國有建設用地使用權,該事項已經公司第二屆董事會第二十三次會議和2020年第三次臨時股東大會審議通過。
近日,子公司珠海賽隆國際投資有限公司以總價人民幣3.29億元成功競拍取得該地塊的國有建設用地使用權,並於2020年6月30日與珠海市公共資源交易中心簽訂了《珠海市公共資源交易中心成交確認書》。
用途:商業性辦公用地;出讓面積:7977.66㎡;容積率:≤6.0;建築密度:一級建築覆蓋率≤50%,二級建築覆蓋率≤30%;綠地率:≥20%;出讓年限:40年。
此次參與競拍國有建設用地使用權是為了落實公司與珠海市香洲區投資促進服務中心簽訂的《項目投資協議書》及與中信城開簽訂的《總部項目合作協議》,推進公司總部及研究院建設。此次競拍成功對公司發展將起到積極的推動作用,為公司未來產業和產品的轉型升級提供保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.